Axsome Therapeutics, Inc. (AXSM)
NASDAQ·Healthcare·Biotechnology
$213.37
+1.05%
Mkt Cap $10.86B
Analyst Ratings
Buy
22
Hold
1
Sell
0
Price Target (71 analysts)
$262.38
Range $200.00 – $380.00
Implied Upside
+23.0%
Consensus $262.38 vs current $213.37